公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2007 | Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV. | Liu, CH; Chen, DS; Kao, JH. | New Engl J Med | | | |
2008 | Peginterferon alfa-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial | Liu, CH; Liu, CJ; Lin, CL; Liang, CC; Hsu, SJ; Yang, SS; Hsu, CS; Tseng, TC; Wang, CC; Lai, MY; Chen, JH; Chen, PJ; Chen, DS; Kao, JH | Clin Infect Dis | | | |
2005 | Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. | Chang, MH; Chen, THH; Hsu, HM; Wu, TC; Kong, MS; Liang, DC; Ni, YH; Chen, CJ; Chen, DS | Clin Cancer Res | | | |
2008 | Serum N-Glycoprotein Biomarker Candidates for Hepatitis C related Liver fibrosis. | Tang, WC; Lai MY Lin, TY; Chen, DS; Beretta, L; Lin, SB | Clin Chem | | | |
2005 | Taiwan Childhood HCC Study Group. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems | Chang, MH; Chen, THH; Hsu, HM; Wu, TC; Kong, MS; Liang, DC; Ni, YH; Chen, CJ; Chen, DS | Clinical Cancer Research | | | |